Carbonyl reductase 1 (CBR1 or SDR21C1) is a ubiquitously-expressed, cytosolic, monomeric, and NADPH-dependent enzyme. CBR1 participates in apoptosis, carcinogenesis and drug resistance, and has a protective role in oxidative stress, cancer and neurodegeneration. S-Nitrosoglutathione (GSNO) represents the newest addition to its diverse substrate spectrum, which includes a wide range of xenobiotics and endogenous substances. GSNO has also been shown to covalently modify and inhibit CBR1. The aim of the present study was to quantify and characterize the resulting modifications. Of five candidate cysteines for modification by 2 mM GSNO (positions 26, 122, 150, 226, 227), the last four were analyzed using MALDI-TOF/TOF mass spectrometry and then quantified using the Selected Reaction Monitoring Approach on hyphenated HPLC with a triple quadrupole mass spectrometer. The analysis confirmed GSNO concentration-dependent S-glutathionylation of cysteines at positions 122, 150, 226, 227 which was 2-700 times higher compared to wild-type CBR1 (WT-CBR1). Moreover, a disulfide bond between neighboring Cys-226 and Cys-227 was detected. We suggest a role of these two cysteines as a redox-sensitive cysteine pair. The catalytic properties of wild-type and enzyme modified with 2 mM GSNO were also investigated by steady state kinetic experiments with various substrates. GSNO treatment of CBR1 resulted in a 2-5-fold decrease in kcat with menadione, 4-benzoylpyridine, 2,3-hexanedione, daunorubicin and 1,4-naphthoquinone. In contrast, the same treatment increased kcat for substrates containing a 1,2-diketo group in a ring structure (1,2-naphthoquinone, 9,10-phenanthrenequinone, isatin). Except for 9,10-phenanthrenequinone, all changes in kcat were at least in part compensated for by a similar change in Km, overall yielding no drastic changes in catalytic efficiency. The findings indicate that GSNO-induced covalent modification of cysteine residues affects the kinetic mechanism of CBR1 both in terms of substrate binding and turnover rate, probably by covalent modification of Cys-226 and/or Cys-227.

Department of Biochemical Sciences Faculty of Pharmacy Charles University Hradec Králové Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc13031734

003      

CZ-PrNML

005      

20131007114738.0

007      

ta

008      

131002s2013 ie f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.cbi.2012.12.011 $2 doi

035    __

$a (PubMed)23295225

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ie

100    1_

$a Hartmanová, Tereza $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.

245    10

$a S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity / $c T. Hartmanová, V. Tambor, J. Lenčo, CA. Staab-Weijnitz, E. Maser, V. Wsól,

520    9_

$a Carbonyl reductase 1 (CBR1 or SDR21C1) is a ubiquitously-expressed, cytosolic, monomeric, and NADPH-dependent enzyme. CBR1 participates in apoptosis, carcinogenesis and drug resistance, and has a protective role in oxidative stress, cancer and neurodegeneration. S-Nitrosoglutathione (GSNO) represents the newest addition to its diverse substrate spectrum, which includes a wide range of xenobiotics and endogenous substances. GSNO has also been shown to covalently modify and inhibit CBR1. The aim of the present study was to quantify and characterize the resulting modifications. Of five candidate cysteines for modification by 2 mM GSNO (positions 26, 122, 150, 226, 227), the last four were analyzed using MALDI-TOF/TOF mass spectrometry and then quantified using the Selected Reaction Monitoring Approach on hyphenated HPLC with a triple quadrupole mass spectrometer. The analysis confirmed GSNO concentration-dependent S-glutathionylation of cysteines at positions 122, 150, 226, 227 which was 2-700 times higher compared to wild-type CBR1 (WT-CBR1). Moreover, a disulfide bond between neighboring Cys-226 and Cys-227 was detected. We suggest a role of these two cysteines as a redox-sensitive cysteine pair. The catalytic properties of wild-type and enzyme modified with 2 mM GSNO were also investigated by steady state kinetic experiments with various substrates. GSNO treatment of CBR1 resulted in a 2-5-fold decrease in kcat with menadione, 4-benzoylpyridine, 2,3-hexanedione, daunorubicin and 1,4-naphthoquinone. In contrast, the same treatment increased kcat for substrates containing a 1,2-diketo group in a ring structure (1,2-naphthoquinone, 9,10-phenanthrenequinone, isatin). Except for 9,10-phenanthrenequinone, all changes in kcat were at least in part compensated for by a similar change in Km, overall yielding no drastic changes in catalytic efficiency. The findings indicate that GSNO-induced covalent modification of cysteine residues affects the kinetic mechanism of CBR1 both in terms of substrate binding and turnover rate, probably by covalent modification of Cys-226 and/or Cys-227.

650    _2

$a alkoholoxidoreduktasy $x metabolismus $7 D000429

650    _2

$a sekvence aminokyselin $7 D000595

650    _2

$a cystein $x metabolismus $7 D003545

650    _2

$a daunomycin $x metabolismus $x farmakologie $7 D003630

650    _2

$a hexanony $x metabolismus $x farmakologie $7 D006588

650    _2

$a lidé $7 D006801

650    _2

$a kinetika $7 D007700

650    _2

$a molekulární sekvence - údaje $7 D008969

650    _2

$a naftochinony $x metabolismus $x farmakologie $7 D009285

650    _2

$a oxidace-redukce $x účinky léků $7 D010084

650    _2

$a pyridiny $x metabolismus $x farmakologie $7 D011725

650    _2

$a S-nitrosoglutathion $x metabolismus $x farmakologie $7 D026422

650    _2

$a vitamin K 3 $x metabolismus $x farmakologie $7 D024483

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Tambor, Vojtěch $u -

700    1_

$a Lenčo, Juraj $u -

700    1_

$a Staab-Weijnitz, Claudia A $u -

700    1_

$a Maser, Edmund $u -

700    1_

$a Wsól, Vladimír $u -

773    0_

$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 202, č. 1-3 (2013), s. 136-45

856    41

$u https://pubmed.ncbi.nlm.nih.gov/23295225 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20131002 $b ABA008

991    __

$a 20131007115259 $b ABA008

999    __

$a ok $b bmc $g 995821 $s 830179

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2013 $b 202 $c 1-3 $d 136-45 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111

LZP    __

$a Pubmed-20131002